KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $24.0 million.

  • Organon's Share-based Compensation fell 400.0% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.0 million, marking a year-over-year decrease of 943.4%. This contributed to the annual value of $105.0 million for FY2024, which is 396.04% up from last year.
  • According to the latest figures from Q3 2025, Organon's Share-based Compensation is $24.0 million, which was down 400.0% from $22.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Share-based Compensation registered a high of $28.0 million during Q2 2024, and its lowest value of $11.0 million during Q1 2021.
  • For the 5-year period, Organon's Share-based Compensation averaged around $21.6 million, with its median value being $23.0 million (2022).
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 8750.0% in 2021, then crashed by 2142.86% in 2025.
  • Quarter analysis of 5 years shows Organon's Share-based Compensation stood at $15.0 million in 2021, then soared by 53.33% to $23.0 million in 2022, then increased by 17.39% to $27.0 million in 2023, then decreased by 3.7% to $26.0 million in 2024, then decreased by 7.69% to $24.0 million in 2025.
  • Its last three reported values are $24.0 million in Q3 2025, $22.0 million for Q2 2025, and $24.0 million during Q1 2025.